Cargando…
Liver Fat Content in Type 2 Diabetes: Relationship With Hepatic Perfusion and Substrate Metabolism
OBJECTIVE: Hepatic steatosis is common in type 2 diabetes. It is causally linked to the features of the metabolic syndrome, liver cirrhosis, and cardiovascular disease. Experimental data have indicated that increased liver fat may impair hepatic perfusion and metabolism. The aim of the current study...
Autores principales: | Rijzewijk, Luuk J., van der Meer, Rutger W., Lubberink, Mark, Lamb, Hildo J., Romijn, Johannes A., de Roos, Albert, Twisk, Jos W., Heine, Robert J., Lammertsma, Adriaan A., Smit, Johannes W.A., Diamant, Michaela |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963532/ https://www.ncbi.nlm.nih.gov/pubmed/20693345 http://dx.doi.org/10.2337/db09-1201 |
Ejemplares similares
-
Fatty liver in uncomplicated type 2 DM is associated with impaired myocardial HEP metabolism, modulated by myocardial glucose uptake
por: Jonker, Jacqueline T, et al.
Publicado: (2009) -
Activin a is associated with impaired myocardial glucose metabolism and left ventricular remodeling in patients with uncomplicated type 2 diabetes
por: Chen, Weena JY, et al.
Publicado: (2013) -
Pioglitazone alters fat distribution in patients with type 2 diabetes mellitus, in contrast to metformin
por: Jonker, Jacqueline T, et al.
Publicado: (2009) -
Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men
por: Chen, Weena JY, et al.
Publicado: (2011) -
Right Ventricular Involvement in Diabetic Cardiomyopathy
por: Widya, Ralph L., et al.
Publicado: (2013)